TCL Archive Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy May 30, 2014
TCL Archive In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982 June 11, 1982